GR3005677T3 - - Google Patents

Info

Publication number
GR3005677T3
GR3005677T3 GR920402003T GR920402003T GR3005677T3 GR 3005677 T3 GR3005677 T3 GR 3005677T3 GR 920402003 T GR920402003 T GR 920402003T GR 920402003 T GR920402003 T GR 920402003T GR 3005677 T3 GR3005677 T3 GR 3005677T3
Authority
GR
Greece
Application number
GR920402003T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005677T3 publication Critical patent/GR3005677T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
GR920402003T 1987-01-28 1992-09-10 GR3005677T3 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882087 1987-01-28
JP6535287 1987-03-18

Publications (1)

Publication Number Publication Date
GR3005677T3 true GR3005677T3 (el) 1993-06-07

Family

ID=26355556

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402003T GR3005677T3 (el) 1987-01-28 1992-09-10

Country Status (6)

Country Link
EP (1) EP0284180B1 (el)
KR (1) KR930006192B1 (el)
CA (1) CA1323364C (el)
DE (1) DE3873797T2 (el)
ES (1) ES2043798T3 (el)
GR (1) GR3005677T3 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DE69213057T2 (de) * 1991-03-14 1997-01-09 R Tech Ueno Ltd Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
AU739343B2 (en) * 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist
BR0009520A (pt) 1999-04-01 2002-06-11 Esperion Therapeutics Inc Composto, método para sintetizar o mesmo, composição, metódos para o tratramento ou prevenção, em um paciente, de doença cardiovascular, dislipidemia, dislipoproteinemia, distúrbio de metabolismo de glucose, doença de alzheimer, sìndrome x ou sìndrome metabólica, septicemia, distúrbio trombótico, distúrbio associado com receptor ativado por proliferador de peroxissoma, obesidade, pancreatite, hipertensão, doença renal, câncer, inflamação, impotência, para reduzir o teor de gordura de carne de gado bovino, e, para reduzir o teor de colesterol de ovos de aves
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins

Also Published As

Publication number Publication date
DE3873797D1 (de) 1992-09-24
DE3873797T2 (de) 1993-01-21
KR930006192B1 (ko) 1993-07-08
EP0284180B1 (en) 1992-08-19
EP0284180A1 (en) 1988-09-28
ES2043798T3 (es) 1994-01-01
KR880008985A (ko) 1988-09-13
CA1323364C (en) 1993-10-19

Similar Documents

Publication Publication Date Title
DE3890135T (el)
DE3882318D1 (el)
DE8704632U1 (el)
DE8703051U1 (el)
DE8701368U1 (el)
DE8702730U1 (el)
CH677303GA3 (el)
DE8702085U1 (el)
DE8702693U1 (el)
DE8704723U1 (el)
DE8703060U1 (el)
DE8704378U1 (el)
DE8700325U1 (el)
DE8703860U1 (el)
DE8703685U1 (el)
DE8702477U1 (el)
DE8704710U1 (el)
DE8702199U1 (el)
DE8701946U1 (el)
DE8701175U1 (el)
DE8700232U1 (el)
DE8704805U1 (el)
DE8703792U1 (el)
DE8701827U1 (el)
DE8703253U1 (el)